ANTICORPS ANTI-C-MET, CONJUGUÉ D'ANTICORPS ANTI-C-MET-MÉDICAMENT CYTOTOXIQUE ET LEUR UTILISATION PHARMACEUTIQUE

• 收藏
• 分享

专利权人:

Suzhou Suncadia Biopharmaceuticals Co., Ltd.;Suzhou Suncadia Biopharmaceuticals Co.; Ltd.;Shanghai Hengrui Pharmaceutical Co., Ltd.;Jiangsu Hengrui Medicine Co., Ltd.

发明人:

LIU, Jiajian,ZHANG, Lianshan,TAO, Weikang,FU, Yayuan,ZHANG, Ling,MA, Dong,CUI, Dongbing,WANG, Yali,XU, Jianyan,LIANG, Jindong,ZHANG, Ying,JIANG, Guiyang,QIU, Junzhuan,SUN, Ziyong,ZHA, Jiping,WEI, Jing

申请号：

EP16779555

公开号：

EP3284751A4

申请日:

2016.04.07

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

Provided are an anti-c-Met antibody or antigen binding fragment, and an anti-c-Met antibody-cytotoxic drug conjugate, wherein the antibody or antigen binding fragment is a chimeric antibody or a humanized antibody. Also provided are a pharmaceutical composition containing a humanized anti-c-Met antibody or antigen binding fragment, antibody-cytotoxic drug conjugate, or a pharmaceutically acceptable salt or solvent compound thereof, applied in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/